J.B.Chemicals share price has plunged 4% and is presently trading at Rs 1,880.0.
Meanwhile, the BSE HEALTHCARE index is at 43,838.2 (down 0.9%).
Among the top losers in the BSE HEALTHCARE index today are Sun Pharma (down 3.1%) and CAPLIN POINT (down 2.8%).
MAX HEALTHCARE INSTITUTE (up 2.7%) and KIMS (up 2.4%) are among the top gainers today.
Over the last one year, J.B.Chemicals has moved up from Rs 1,398.7 to Rs 1,880.0, registering a gain of Rs 481.4 (up 34.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,271.8 to 43,838.2, registering a gain of 60.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 235.1%), SUVEN PHARMACEUTICALS (up 126.9%) and Glenmark Pharma (up 124.6%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,073.2 (down 1.0%).
The top losers among the BSE Sensex today are Sun Pharma (down 3.1%) and Infosys (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,076.7 (down 0.9%). Bajaj Auto and IOC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,874.9 to 79,073.2, registering a gain of 15,198.2 points (up 23.8%).
J.B.Chemicals net profit grew 24.2% YoY to Rs 1,768 million for the quarter ended June 2024, compared to a profit of Rs 1,423 million a year ago. Net sales rose 12.1% to Rs 10,044 million during the period as against Rs 8,962 million in April-June 2023.
For the year ended March 2024, J.B.Chemicals reported 34.8% increase in net profit to Rs 5,526 million compared to net profit of Rs 4,100 million during FY23. Revenue of the company grew 10.6% to Rs 34,842 million during FY24.
The current Price to earnings ratio of J.B.Chemicals, based on rolling 12 month earnings, stands at 49.7.
Equitymaster requests your view! Post a comment on "J.B.Chemicals Plunges 4%; BSE HEALTHCARE Index Down 0.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!